vs
ImmunityBio, Inc.（IBRX）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
RMR GROUP INC.的季度营收约是ImmunityBio, Inc.的1.7倍（$66.7M vs $38.3M），RMR GROUP INC.净利率更高（18.3% vs -161.8%，领先180.1%），ImmunityBio, Inc.同比增速更快（407.0% vs 40.8%）
ImmunityBio, Inc.是一家处于临床阶段的生物技术企业，专注开发针对多种癌症及传染性疾病的下一代免疫疗法与候选疫苗，核心研发方向涵盖细胞疗法、抗体药物及靶向疫苗平台，主要运营市场位于美国。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
IBRX vs RMR — 直观对比
营收规模更大
RMR
是对方的1.7倍
$38.3M
营收增速更快
IBRX
高出366.2%
40.8%
净利率更高
RMR
高出180.1%
-161.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $38.3M | $66.7M |
| 净利润 | $-61.9M | $12.2M |
| 毛利率 | 99.0% | — |
| 营业利润率 | -169.0% | 48.1% |
| 净利率 | -161.8% | 18.3% |
| 营收同比 | 407.0% | 40.8% |
| 净利润同比 | -4.7% | 91.1% |
| 每股收益（稀释后） | $-0.06 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IBRXRMR
| Q4 25 | $38.3M | $66.7M | ||
| Q3 25 | $32.1M | — | ||
| Q2 25 | $26.4M | — | ||
| Q1 25 | $16.5M | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.1M | — |
净利润IBRXRMR
| Q4 25 | $-61.9M | $12.2M | ||
| Q3 25 | $-67.3M | — | ||
| Q2 25 | $-92.6M | — | ||
| Q1 25 | $-129.6M | — | ||
| Q4 24 | $-59.2M | — | ||
| Q3 24 | $-85.7M | — |
毛利率IBRXRMR
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
营业利润率IBRXRMR
| Q4 25 | -169.0% | 48.1% | ||
| Q3 25 | -173.5% | — | ||
| Q2 25 | -269.8% | — | ||
| Q1 25 | -390.1% | — | ||
| Q4 24 | -919.0% | — | ||
| Q3 24 | -1314.3% | — |
净利率IBRXRMR
| Q4 25 | -161.8% | 18.3% | ||
| Q3 25 | -209.8% | — | ||
| Q2 25 | -350.3% | — | ||
| Q1 25 | -784.9% | — | ||
| Q4 24 | -783.4% | — | ||
| Q3 24 | -1404.0% | — |
每股收益（稀释后）IBRXRMR
| Q4 25 | $-0.06 | $0.71 | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.08 | — | ||
| Q3 24 | $-0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $242.8M | $49.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-500.5M | $232.7M |
| 总资产 | $501.9M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IBRXRMR
| Q4 25 | $242.8M | $49.3M | ||
| Q3 25 | $257.8M | — | ||
| Q2 25 | $153.7M | — | ||
| Q1 25 | $61.6M | — | ||
| Q4 24 | $149.8M | — | ||
| Q3 24 | $130.4M | — |
股东权益IBRXRMR
| Q4 25 | $-500.5M | $232.7M | ||
| Q3 25 | $-524.3M | — | ||
| Q2 25 | $-570.7M | — | ||
| Q1 25 | $-591.4M | — | ||
| Q4 24 | $-489.1M | — | ||
| Q3 24 | $-745.1M | — |
总资产IBRXRMR
| Q4 25 | $501.9M | $687.1M | ||
| Q3 25 | $519.0M | — | ||
| Q2 25 | $402.1M | — | ||
| Q1 25 | $303.8M | — | ||
| Q4 24 | $382.9M | — | ||
| Q3 24 | $364.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-70.4M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $-71.3M | — |
| 自由现金流率自由现金流/营收 | -186.2% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $-308.8M | — |
8季度趋势，按日历期对齐
经营现金流IBRXRMR
| Q4 25 | $-70.4M | $10.7M | ||
| Q3 25 | $-68.9M | — | ||
| Q2 25 | $-79.7M | — | ||
| Q1 25 | $-85.9M | — | ||
| Q4 24 | $-85.1M | — | ||
| Q3 24 | $-98.8M | — |
自由现金流IBRXRMR
| Q4 25 | $-71.3M | — | ||
| Q3 25 | $-69.6M | — | ||
| Q2 25 | $-80.8M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-87.3M | — | ||
| Q3 24 | $-101.6M | — |
自由现金流率IBRXRMR
| Q4 25 | -186.2% | — | ||
| Q3 25 | -217.2% | — | ||
| Q2 25 | -305.9% | — | ||
| Q1 25 | -526.9% | — | ||
| Q4 24 | -1155.4% | — | ||
| Q3 24 | -1663.2% | — |
资本支出强度IBRXRMR
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | 45.7% | — |
现金转化率IBRXRMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IBRX
暂无分部数据
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
